Statins and cerebral vasomotor reactivity: implications for a new therapy?
Carod-Artal
Francisco Javier
FJ
D000328:Adult; D000818:Animals; D001120:Arginine / Q000494:pharmacology; D000069059:Atorvastatin; D002545:Brain Ischemia / Q000209:etiology / Q000517:prevention & control; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D017322:Clinical Trials, Phase II as Topic; D004730:Endothelium, Vascular / Q000187:drug effects; D006538:Heptanoic Acids / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D006937:Hypercholesterolemia / Q000150:complications; D006973:Hypertension / Q000150:complications; D002532:Intracranial Aneurysm / Q000150:complications; D051379:Mice; D020768:Middle Cerebral Artery / Q000000981:diagnostic imaging; D009569:Nitric Oxide / Q000502:physiology; D017035:Pravastatin / Q000494:pharmacology / Q000627:therapeutic use; D011758:Pyrroles / Q000494:pharmacology / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D012307:Risk Factors; D019821:Simvastatin / Q000494:pharmacology / Q000627:therapeutic use; D020521:Stroke / Q000517:prevention & control; D013345:Subarachnoid Hemorrhage / Q000188:drug therapy / Q000209:etiology; D017585:Ultrasonography, Doppler, Transcranial; D014664:Vasodilation / Q000187:drug effects; D014666:Vasomotor System / Q000187:drug effects*; D020301:Vasospasm, Intracranial / Q000188:drug therapy / Q000209:etiology
D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D009569:Nitric Oxide; D001120:Arginine; D000069059:Atorvastatin; D019821:Simvastatin; D017035:Pravastatin